期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小剂量糖皮质激素不同时间点给药治疗类风湿关节炎疗效观察 被引量：7

下载PDF
导出
摘要 类风湿关节炎（rheumatoidarthritis，RA）是一种以关节滑膜炎症为病理中心的系统性自身免疫病，炎性细胞因子在RA的发病和病理生理过程中发挥重要作用，研究显示，多种炎性细胞因子具有时间节律特征，即炎性细胞因子有生物钟特性，并调控RA症状昼夜节律变化。本文比较小剂量糖皮质激素（GCs）不同时间点给药联合改善病情抗风湿药（DMARDs）治疗类风湿关节炎的疗效以及利益／风险比，探讨小剂量GCs在RA中的时间治疗学。
作者 王文琴 陈飒 许盼盼
机构地区 浙江省金华市人民医院风湿免疫科
出处 《浙江中西医结合杂志》 2014年第10期890-892,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
关键词 类风湿关节炎 小剂量糖皮质激素 给药时间
分类号 R593.22 [医药卫生—内科学]
  • 相关文献

参考文献13

  • 1Kanabrocki EL,Sothem RB,Messmore HL,et al.Ciradianinterrelation ships among levels of plasma fibrinogen,bloodplatelets,and serum interleukin-6[J].Clin Appl ThrombHemost,1999,5(1):34-42.
  • 2Villeneuve E’Nam J,Emery P.2010 ACR-EULAR classifi-cation criteriafor rheumatoid arthritis[J].Rev Bras Rheuma-tol,2010,50(5):481-483.
  • 3Fransen J,Greemers MC,Van Riel PLRemission in rheuma-toid arthritis:agreement of the disease activity score(DAS28)with the ARA preliminary remission criterin[J].Rheumatol-ogy(oxford),2004,43(10):1252.
  • 4Herold M,Gtinther R.Circadian rhythm of C-reative proteinin patients with rheamatoid arthritis[J],Prog dim Biol Res,1987,227B:271-279.
  • 5Kanabrocki EL,Sothem RB,Messore HL,et al.Cir cadianintrerrelationships among levels of plasma fibrinogen,bloodplatelets,and serum interleukin-6[J].Clin Appl ThrombHemost,1999,5(1):37-42.
  • 6Gutolo M,Seriolo B,Crarviotto C,et al.Circadian rhythms inRA[J].Ann Rheum Dis,2003,62(7):593-596.
  • 7Kowanko IC,Knapp MS,Pownall R,et al.Domiciliary Self-measurement in the rheumatoid arthritis and the demonstra-tion of circadian rhythmicity[J].Ann Rheum Dis,1982,41(5):453-455.
  • 8魏天佑,崔燎.骨质疏松与类风湿关节炎[J].中国骨质疏松杂志,2007,13(8):592-595. 被引量：21
  • 9De Jong Z,Mumeke M,Lems WF,et al.Slowing of bone lossin patients with rheumatoid arthritis by long term high in-tensity exercise:results of a rangomized,controlled trial[J].Arthritis Rheum,2004,50(4):1066-1076.
  • 10Todoerti M,Scire CA,Boffini N,et al.Early disease controlby low-close prednisone comedication may affect the qual-ity of remission in patients with early rheumatoid arthritis[J].Ann NY Aad Sci,2010,1193(13):139-145.

二级参考文献20

  • 1徐胜前,邵宜波,徐建华.类风湿性关节炎患者骨密度变化的临床研究[J].临床内科杂志,2004,21(11):763-765. 被引量：16
  • 2黎伟凡,钟紫茹,郑琼美.类风湿性关节炎与骨质疏松关系的探讨[J].齐齐哈尔医学院学报,2005,26(8):880-881. 被引量：3
  • 3张乃峥.类风湿关节炎[A].见:张乃峥主编.临床风湿病学[C].上海:上海科学技术出版社,1999.118—137.
  • 4Haugeberg G,Uhlig T,Falch JA,et al.Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis:results from 394 patients in the Oslo County Rheumatoid Arthritis register.Arthritis Rheum,2000,43 (3):522-530.
  • 5Nolla JM,Roig-Vilaseca D,Gomez-Vaquero C,et al.Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital.J Rheumatol,2006,33:1472-1475.
  • 6Roldan JF,Del Rincon I,Escalante A,et al.Loss of cortical bone from the metacarpal diaphysis in patients with rheumatoid arthritis:independent effects of systemic inflammation and glucocorticoids.J Rheumatol,2006,33:508-516.
  • 7Gravallese EM,Harada Y,Wang JT,et al.Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.Am J Pathol,1998,152:943-951.
  • 8Gravallese EM,Manning C,T say A,et al.Synovial tissue in rheumatoid arthritis a source of osteoclast differentiation factor.Arthritis Rheum,2000,43:250-258.
  • 9Pettit AR,Ji H,Von Stechow D,et al.TRANCE/RANKL knock out mice are protected from bone erosion in a serum transfer model of arthritis.Am J Pathol,2001,159:1689-1699.
  • 10Yasuda H,Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.Proc Natl Acad Sci USA,1998,95:3597-3602.

共引文献20

同被引文献88

  • 1王晋辉.糖皮质激素治疗风湿疾病的效果及不良反应分析[J].中国科技期刊数据库 医药,2021(10):337-338. 被引量：1
  • 2陈英,黄春林.冠心病心律失常昼夜节律与子午流注时辰规律的联系观察[J].新中医,2007,39(9):59-61. 被引量：17
  • 3SmolenJ S, Aletaha D, BijlsmaJ W, et al. Treating rheumatoid arthritis to target: recommendations of all international task force[J]. Ann Rheum Dis,2010 ,69( 4) : 631 -7.
  • 4SmolenJ S, Landewe R, Breedveld Fe, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update[J]. Ann Rheum Dis ,2014 ,73(3) :492 -509.
  • 5Sokka T, Hetland M L, Makinen H, et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries[J] . Arthritis Rheum, 2008, 58 ( 9) : 2642 - 51.
  • 6Bamabe C , Thanh N X, Ohinmaa A, et al. Effect of remission definition on health care cost savings estimates for patients with rheu- matoid arthritis treated with biologic therapies[J].J Rheumatol, 2014,41(8) :1600 -6.
  • 7Wang G Y, Zhang S L, Wang X R, et al. Remission of rheumatoid arthritis and potential determinants: a national multi -center crosssectional surveyT]. Clin Rheumatol,2015 ,34(2) :221 -30.
  • 8Rantalaiho V, Kautiainen H, Korpela M, et al. Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trialj L]. Ann Rheum Dis, 2014, 73(4) :788- 90.
  • 9Bamabe C, Thanh N X, Ohinmaa A, et al. Healthcare service utilisation costs are reduced when rheumatoid arthritis patients achieve sustained remission[J] . Ann Rheum Dis, 2013,72 ( 10) : 1664 -8.
  • 10Choy T, Bykerk V P, Boire G, et al. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort[J]. Rheuma-tology, 2014, 53 (3) :482 - 90.

引证文献7

二级引证文献34

浙江中西医结合杂志
2014年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部